Abstract
Introduction
It would be desirable to have preoperative methods that allow an adequate selection of patients with breast lesions to rule out breast cancer: The aim of the present study is to evaluate the efficiency of preoperative Sestamibi gammagraphy and Doppler sonography regarding the differential diagnosis of malignancy in breast lesions.
Material and methods
A prospective observational study was conducted on 88 consecutive patients with breast lesions. All the patients underwent preoperative Doppler sonogrpahy with an echo-enhancing agent and Sestamibi gammagraphy. All the patients had histopathological study of the surgical specimen to compare with the result of the preoperative techniques. These comparations were done both for the overall series and separately for palpable and non-palpable lesions.
Results
In the overall series results, both tests separately and the two combined, are related significantly to the malignant histological diagnosis (p<0.001). In palpable lesions, there is a considerable increase in sensitivity, and especially in specificity, attaining 100%, with the combination of both tests. In non-palpable lesions, a relationship was only found between the results of the Sestamibi gammagraphy and the malignant histological diagnosis (93.3%; p<0.05).
Conclusions
Sestamibi gammagraphy and Doppler sonography are two efficient exploratory techniques in the preoperative assessment of malignancy in breast lesions, especially for palpable lesions, and this efficiency is greater when they are combined.
Similar content being viewed by others
References
Waxman AD. The role of 99mTc-methoxyiso butylisonitrile in imaging breast cancer. Sem Nucl Med. 1997;27:40–54.
Kopans DB. The positive predictive value of mammography. Am J Roentgenol. 1992; 158:521–6.
Bombardieri E, Crippa F, Maffioli G, Greco M. Nuclear Medicine techniques for the study of breast cancer. Eur J Nucl Med. 1997;24:809–24.
Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg. 1994;178:491–7.
Palmedo H, Grünwald F, Bender H, et al. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging. Eur J Nucl Med. 1996;23:940–6.
Koukouraki S, Koukouraki MI, Vagios E, Velidaki A, Tsiftsis D, Karkavitsas N. The role of 99mTc-sestamibi scintimammography and colour Doppler ultrasonography in the evaluation of breast lesions. Nucl Med Commun. 2001;22:1245–8.
Taillefer R, Robidoux A, Lambert R, Turpin S, Laperrier J. Technetium 99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med. 1995;56:1758–65.
Raza S, Baum JK. Solid breast lesions: evaluation with power Doppler ultrasound. Radiology. 1997;205:164–8.
Özdemir A, Özdemir H, Maral I, Konus Ö, Yücel S, Isik S. Differential diagnosis of solid breast lesions: contribution of Doppler studies to mammography and gray scale imagines. J Ultrasound Med. 2001;20:1091–101.
Jackson VP. The current role of ultrasonography in breast imaging. Radiol Clin North Am. 1995;55:1161–70.
Milz P, Lienemann A, Kessler M, Reiser M. Evaluation of breast lesions by power Doppler sonography. Eur Radiol. 2001;11: 547–54.
Piñero A, Reus M, Illana J, et al. Palpable breast lesions: utility of Doppler sonography for diagnosis of malignancy. Breast. 2003;12:258–63.
Canby R, Silver S, Pohost G. Relations of the myocardial imaging agents 99m-TcMIBI and 201-T1 to myocardial blood flow in a canine model of myocardial ischemic insult. Circulation. 1990;81:289–96.
Khalkhali I, Mishkin F, Diggles L, Klein SR. Radionuclide-guided sterotatic prebiopsy localization of nonpalpable breast lesions with normal mammograms. J Nucl Med. 1997;58:1019–22.
McHenry CR, Lee K, Saadey J, Neumann DR, Esselstyn CB. Parathyroid localization with technetium 99m sestamibi: a prospective evaluation. J Am Coll Surg. 1996;185:25–30.
O’Doherty MJ, Keetle AG, Wells P, Collins REC, Cookley AJ. Parathyroid imaging with technetium 99 m Sestamibi: preoperative localization and tissue uptake studies. J Nucl Med. 1992;33:313–8.
Lee VS, Wilkinson RH, Leight GS, Coogan AG, Coleman RE. Hyperparathyroidism in high risk surgical patients: evaluation with double-phase technetium 99m sestamibi imaging. Radiology. 1995;197:627–33.
Kim SW, Park SS, Ahn SJ, et al. Identification of angiogenesis in primary breast carcinoma according to the image análisis. Breast Cancer Res Treat 2002;74:121–9.
Chiu M, Krounage J, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts. J Nucl Med. 1990;51:1646–53.
Piñero A, Rodríguez JM, Ortiz, S, et al. Estudio del contenido mitocondrial en adenomas paratiroideos y su correlación con la gammagrafia con Tc99m-Sestamibi. Cirugia Española. 1999;66:285–8.
Cutrone JA, Yospur LS, Khalkhali I, et al. Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions. J Nucl Med. 1998; 39:449–53.
Bonazzi G, Cistaro A, Belló M, et al. Breast cancer cellular proliferation indexes and 99mTc sestamibi capture: What correlation? J Exp Clin Cancer Res. 2001; 20:91–4.
Piñero A, Rodríguez JM, Martínez-Barba E, Canteras M, Sitges-Serra A, Parrilla P. Tc99m-sestamibi scintigraphy and cell proliferation in primary hyperparathyroidism: a causal or casual relationship? Surgery 2003;134:41–4.
Piwnica-Worms D, Chiu M, Budding M, Krounage JF, Kramer RA, Croup JM. Functional imaging of multidrug resistant p-glycoprotein with an organotechnetium complex. Cancer Res. 1993;53:977–84.
Del Vecchio S, Ciarmiello A, Potena M, et al.In vivo detection of multidrug resistant (MDR1) phenotype by technetium 99m sestamibi scan in untreated breast cancer patients. Eur J Nucl Med. 1997;24:150–9.
Del Vecchio S, Ciarmiello A, Pace L, et al. Fractional retention of technetium 99 m sestamibi as an index of p glycoprotein expression in untreated breast cancer patients. J Nucl Med. 1997;38:1348–51.
Burak Z, Argon M, Memi S. Evaluation of palpable breast masses with Tc99m MI-BI: a comparative study with mammography and ultrasonography. Nucl Med Commun. 1994;15:604–12.
Kao C, Wang S, Liu T. The use of Tc99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med. 1994;21:432–6.
Lam W, Yang W, Chan Y, Stewart IE, Metreweli C, King W. Detection of axillary lymph node metastases in breast carcinoma by technetium 99m sestamibi scintigrphy, ultrasound and conventional mammography. Eur J Nucl Med. 1996;23:498–503.
Clifford E, Lugo-Zambudio C, Kao C. Tc99m MIBI uptake in breast carcinoma and axillary lymph node metastases. Am J Surg. 1996;172:483–6.
Howarth D, Sillar R, Clark D, Lan L. Technetium-99m sestamibi scintimammography: the influence of histopathological characteristics, lesion size and the presence of carcinomain situ in the detection of breast carcinoma. Eur J Nucl Med. 1999;26:1475–81.
Wang HC, Sun SS, Kao A, Lin CC, Lee CC. Comparison of technetium-99m methoxyisobutylisonitrile scintimammography and ultrasonography in the diagnosis of breast cancer in patients with mammographically dense breast. Cancer Invest. 2002;20:318–25.
Liberman M, Sampalis F, Mulder DS, Sampalis JS. Breast cancer diagnosis by scintimammography: a meta-analysis and review of the literature. Breast Cancer Res Treat. 2003;80:115–26.
Waxman A, Nagaraj N, Ashok G. Sensitivity and especifity of 99mTc methoxyi-sobutylisonitrile (MIBI) in the evaluation of primary carcinoma of the breast: comparison of palpable and nonpal-pable lesions with mammography (abstract). J Nucl Med. 1994;35:22.
Villanueva-Meyer J, Leonard M, Briscoe E, et al. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer. J Nucl Med. 1996;37:926–30.
Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions. J Nucl Med. 1998;39:86–91.
Folkman J. Angiogenesis and tumor growth. N Eng J Med. 1996;334:921–8.
Watermann D, Madjar H, Sauerbrei W, Hirt V, Prompeler H, Stickeler E. Assessment of breast cancer vascularisation by Doppler ultrasound as a prognostic factor of survival. Oncol Rep. 2004;11:905–10.
Madjar H, Prompeler HJ, Del Favero C, Hackelöer BJ, Lull JB. A new Doppler signal enhancing agent for flow assessment in breast lesions. Eur J Ultrasound. 2000;12:123–30.
Madjar H, Sauerbrei W, Prömpeler HJ, Wolfarth R, Gufler H. Color Doppler and duplex flow analisis for classification of breast lesions. Gynecol Oncol. 1997;64:392–403.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Piñero, A., Galindo, P.J., Illana, J. et al. Diagnostic efficiency of Sestamibi gammagraphy and Doppler sonography in the preoperative assessment of breast lesions. Clin Transl Oncol 8, 103–107 (2006). https://doi.org/10.1007/s12094-006-0166-x
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s12094-006-0166-x